CME Group (CME) reported $1.64 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 10.4%. EPS of $2.80 for the same period compares to $2.50 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $1.65 billion, representing a surprise of -0.46%. The company delivered an EPS surprise of +0.36%, with the consensus EPS estimate being $2.79.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how CME performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average daily volume (including NYMEX and COMEX): 29.77 million versus the five-analyst average estimate of 29.27 million.
- Average daily volume - Interest rates (including NYMEX and COMEX): 15.03 million versus the five-analyst average estimate of 14.93 million.
- Average daily volume - Equity indexes (including NYMEX and COMEX): 8 million versus the five-analyst average estimate of 7.77 million.
- Average daily volume - Foreign exchange (including NYMEX and COMEX): 1.15 million versus the five-analyst average estimate of 1.13 million.
- Average daily volume - Energy (including NYMEX and COMEX): 2.9 million compared to the 2.83 million average estimate based on five analysts.
- Average daily volume - Agricultural commodities (including NYMEX and COMEX): 1.96 million compared to the 1.91 million average estimate based on five analysts.
- Average rate per contract - Metals (including NYMEX and COMEX): $1.59 compared to the $1.58 average estimate based on five analysts.
- Average rate per contract (including NYMEX and COMEX): $0.69 compared to the $0.71 average estimate based on five analysts.
- Average rate per contract - Interest rates (including NYMEX and COMEX): $0.48 versus $0.49 estimated by five analysts on average.
- Revenues- Clearing and transaction fees: $1.34 billion compared to the $1.35 billion average estimate based on seven analysts. The reported number represents a change of +10.6% year over year.
- Revenues- Other: $110.50 million versus $112.11 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +6.7% change.
- Revenues- Market data and information services: $194.50 million versus $186.41 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +10.9% change.
View all Key Company Metrics for CME here>>>
Shares of CME have returned +1.3% over the past month versus the Zacks S&P 500 composite's -6.6% change. The stock currently has a Zacks Rank #1 (Strong Buy), indicating that it could outperform the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
CME Group Inc. (CME): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
